Related Experiment Video For cancer intervention
Updated: Dec 8, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Microsatellite instability driven metastatic parathyroid carcinoma managed with the anti-PD1 immunotherapy,
Daniel Park1, Rany Airi2, Michael Sherman3
1Internal Medicine, Touro University California, Vallejo, California, USA Daniel.park2@tu.edu.
Abstract:
The present case report describes a 65-year-old man with Lynch syndrome and hypercalcaemia associated with hyperparathyroidism. Parathyroid surgery confirmed the diagnosis of parathyroid carcinoma. Serum calcium and parathyroid hormone (PTH) concentrations serially increased after initial surgery. Imaging study and subsequent biopsy confirmed lung metastases with mismatch repair deficiency. Pembrolizumab was initiated achieving 60% reduction in tumour burden.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy

